Fuchs’ Endothelial Corneal Dystrophy
Also known as: FECD, Fuchs dystrophy, Cornea guttata
Overview
Fuchs’ endothelial corneal dystrophy is a progressive, bilateral disorder in which corneal endothelial cells are lost and guttae accumulate on Descemet membrane, impairing the endothelium’s ability to keep the cornea dehydrated. The result is corneal edema, glare, and characteristic vision that is blurriest on waking. Endothelial keratoplasty—DMEK or DSAEK—is the definitive treatment for visually significant disease.
- Affected layer
- Corneal endothelium
- Hallmark sign
- Guttae on Descemet membrane
- Classic symptom
- Blur worst in the morning
- Definitive care
- DMEK / DSAEK
Key clinical points
- Guttae are the earliest clinical sign, often preceding symptoms by years.
- Endothelial cells do not regenerate, so loss is cumulative and progressive.
- Cataract surgery can accelerate decompensation and requires careful planning in Fuchs’ patients.
- DMEK offers faster recovery and better acuity than DSAEK for suitable eyes.
- Emerging cell-based and Descemet-stripping-only approaches are under investigation.
Pathophysiology and presentation
The corneal endothelium maintains stromal deturgescence through active pumping. In Fuchs’ dystrophy, progressive endothelial cell loss and guttae reduce this pumping capacity. When cell density falls below a critical threshold, the cornea swells, producing stromal and epithelial edema.
Patients classically report vision that is worst upon waking and improves through the day as evaporation reduces corneal hydration. Advanced disease causes persistent edema, painful epithelial bullae, and reduced acuity.
Diagnosis
Slit-lamp examination reveals central guttae and, in advanced disease, corneal edema. Specular microscopy documents endothelial cell density and morphology, and corneal pachymetry and tomography quantify thickness and help track progression.
Preoperative assessment is especially important before cataract surgery, since endothelial stress from surgery can precipitate decompensation and change surgical planning.
Management
Early disease may be observed, with hypertonic saline to reduce epithelial edema and symptomatic support. When vision or comfort is significantly affected, endothelial keratoplasty replaces the diseased endothelium. Descemet membrane endothelial keratoplasty (DMEK) transplants only Descemet membrane and endothelium, offering excellent visual outcomes and low rejection rates; DSAEK remains valuable in complex eyes.
In patients with concurrent cataract, combined or staged procedures are planned based on endothelial reserve.
Fuchs’ Endothelial Corneal Dystrophy videos
Frequently asked questions
- Why is vision worse in the morning with Fuchs’ dystrophy?
- During sleep the eyelids are closed and tear evaporation stops, so the already-compromised cornea retains more fluid and swells overnight. Vision then improves through the day as evaporation reduces corneal hydration.
- What is the difference between DMEK and DSAEK?
- Both replace diseased corneal endothelium, but DMEK transplants only the thin Descemet membrane and endothelium for faster recovery and sharper vision, while DSAEK includes a thin layer of stroma and can be easier to handle in complex eyes.
- Does Fuchs’ dystrophy affect cataract surgery?
- Yes. Cataract surgery stresses the corneal endothelium and can accelerate decompensation in Fuchs’ patients, so surgeons assess endothelial reserve and may plan combined or staged endothelial keratoplasty.
References & further reading
Related conditions
Cataracts
A cataract is any opacification of the crystalline lens that degrades vision, most commonly from age-related changes. It is the leading cause of reversible blindness worldwide and is treated definitively with surgical lens removal and intraocular lens (IOL) implantation. Modern phacoemulsification is among the most frequently performed and successful procedures in medicine.
Clinical overviewCornea & Ocular SurfaceDry Eye Disease
Dry eye disease is a multifactorial disease of the ocular surface characterized by loss of tear film homeostasis, accompanied by ocular symptoms, in which tear film instability, hyperosmolarity, inflammation, and neurosensory abnormalities play etiological roles. It is among the most common reasons patients present to eyecare providers. Management is staged and targets the underlying subtype—aqueous-deficient, evaporative, or mixed.
Clinical overview

